mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
-0.15 |
0.6 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
BRD-K64610608 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
purmorphamine |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
MI-1 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
VER-155008 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
PRIMA-1-Met |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.6 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |